Z-W Zhang1, M Abdullahi, M J G Farthing. 1. Digestive Diseases Research Centre, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK. z.w.zhang@bristol.ac.uk
Abstract
BACKGROUND: Gastric juice vitamin C may be protective against gastric carcinogenesis but concentrations are significantly reduced by Helicobacter pylori infection. We investigated the in vitro effects of vitamin C at concentrations comparable with those found in gastric juice on gastric cancer cells and H pylori. METHODS: Gastric cancer cell lines and various H pylori strains were treated with L-ascorbic acid for up to 72 hours. Cell viability, and protein and DNA synthesis were determined. Flow cytometry was used for assessment of H pylori adherence, cell cycle distribution, and apoptosis. H pylori growth and its haemagglutination activity were determined using viability count and microtitration assay. RESULTS: Vitamin C induced a significant dose dependent growth inhibition of gastric AGS and MKN45 cells but this effect was significantly reduced at levels similar to those in gastric juice of H pylori infected patients (<50 microM). Although vitamin C had no obvious effect on H pylori growth, haemagglutination activity, or adherence ability to gastric AGS cells compared with untreated controls, it significantly enhanced H pylori associated apoptosis and induced cell cycle arrest in these cells. CONCLUSION: Vitamin C may inhibit gastric cancer cell growth and alter H pylori induced cell cycle events at concentrations comparable with those in gastric juice, but has no effect on H pylori growth or pathogenicity. However, the inhibitory effect on gastric cancer cells was lost at vitamin C concentrations found in patients with H pylori infection.
BACKGROUND: Gastric juice vitamin C may be protective against gastric carcinogenesis but concentrations are significantly reduced by Helicobacter pyloriinfection. We investigated the in vitro effects of vitamin C at concentrations comparable with those found in gastric juice on gastric cancer cells and H pylori. METHODS:Gastric cancer cell lines and various H pylori strains were treated with L-ascorbic acid for up to 72 hours. Cell viability, and protein and DNA synthesis were determined. Flow cytometry was used for assessment of H pylori adherence, cell cycle distribution, and apoptosis. H pylori growth and its haemagglutination activity were determined using viability count and microtitration assay. RESULTS:Vitamin C induced a significant dose dependent growth inhibition of gastric AGS and MKN45 cells but this effect was significantly reduced at levels similar to those in gastric juice of H pylori infectedpatients (<50 microM). Although vitamin C had no obvious effect on H pylori growth, haemagglutination activity, or adherence ability to gastric AGS cells compared with untreated controls, it significantly enhanced H pylori associated apoptosis and induced cell cycle arrest in these cells. CONCLUSION:Vitamin C may inhibit gastric cancer cell growth and alter H pylori induced cell cycle events at concentrations comparable with those in gastric juice, but has no effect on H pylori growth or pathogenicity. However, the inhibitory effect on gastric cancer cells was lost at vitamin C concentrations found in patients with H pylori infection.
Authors: Tram Kim Lam; Neal D Freedman; Jin-Hu Fan; You-Lin Qiao; Sanford M Dawsey; Philip R Taylor; Christian C Abnet Journal: Am J Clin Nutr Date: 2013-09-11 Impact factor: 7.045
Authors: Tianyi Wang; Hui Cai; Shizuka Sasazuki; Shoichiro Tsugane; Wei Zheng; Eo Rin Cho; Sun Ha Jee; Angelika Michel; Michael Pawlita; Yong-Bing Xiang; Yu-Tang Gao; Xiao-Ou Shu; Wei-Cheng You; Meira Epplein Journal: Int J Cancer Date: 2016-10-31 Impact factor: 7.396
Authors: Claudia P M S Oliveira; Paulo Kassab; Fabio P Lopasso; Heraldo P Souza; Mariano Janiszewski; Francisco R M Laurindo; Kioshi Iriya; Antonio A Laudanna Journal: World J Gastroenterol Date: 2003-03 Impact factor: 5.742